Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia

MLA

S, Drunat, et al. “Quantification of TEL-AML1 Transcript for Minimal Residual Disease Assessment in Childhood Acute Lymphoblastic Leukaemia.” British Journal of Haematology, vol. 114, no. 2, Sept. 2001. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........68dc55399e53ed3a8df253cc1c1ddf3f&authtype=sso&custid=ns315887.

APA

S, D., M, O., G, B., B, G., E, V., I, B., & H, C. (2001). Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 114(2).

Chicago

S, Drunat, Olivi M, Brunie G, Grandchamp B, Vilmer E, Bièche I, and Cavé H. 2001. “Quantification of TEL-AML1 Transcript for Minimal Residual Disease Assessment in Childhood Acute Lymphoblastic Leukaemia.” British Journal of Haematology 114 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........68dc55399e53ed3a8df253cc1c1ddf3f&authtype=sso&custid=ns315887.